Published in Am J Physiol on August 01, 1963
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther (1957) 3.99
Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03
Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem (1954) 2.78
A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci (1957) 2.71
Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther (1958) 2.37
Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26
Evidence that serotonin has a role in brain function. Science (1955) 2.13
Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99
Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther (1957) 1.86
Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther (1959) 1.63
BINDING AND RELEASE OF METARAMINOL: MECHANISM OF NOREPINEPHRINE DEPLETION BY ALPHA-METHYL-M-TYROSINE AND RELATED AGENTS. J Pharmacol Exp Ther (1964) 1.56
Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science (1957) 1.54
Release of serotonin and catecholamines by drugs. Pharmacol Rev (1962) 1.53
Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835). J Pharmacol Exp Ther (1960) 1.41
Role of brain serotonin in reserpine action. Ann N Y Acad Sci (1957) 1.40
Release of serotonin from blood platelets by reserpine in vitro. J Pharmacol Exp Ther (1957) 1.39
Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain. J Neurochem (1961) 1.35
RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION. Science (1964) 1.33
MECHANISM OF ACTION OF RESERPINE AND INSULIN ON GASTRIC AMINES AND GASTRIC ACID SECRETION, AND THE EFFECT OF MONOAMINE OXIDASE INHIBITION. J Pharmacol Exp Ther (1963) 1.28
Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Ann N Y Acad Sci (1959) 1.17
Interaction of drugs with norepinephrine in the brain. Pharmacol Rev (1959) 1.15
Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system. Experientia (1955) 1.14
Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase. Biochem Pharmacol (1960) 1.14
On the mechanism of action of reserpine: effect of reserpine on capacity of tissues to bind serotonin. J Pharmacol Exp Ther (1957) 1.13
Serotonin storage mechanism and its interaction with reserpine. Experientia (1958) 1.04
FLUOROMETRIC ESTIMATION OF METARAMINOL AND RELATED COMPOUNDS. Life Sci (1964) 1.01
Serotonin changes in platelets and brain induced by small daily doses of reserpine; lack of effect of depletion of platelet serotonin on hemostatic mechanisms. N Engl J Med (1957) 0.98
A simple technique involving solvent extraction for the estimation of norepinephrine and epinephrine in tissues. Pharmacol Rev (1959) 0.97
Distribution of norepinephrine in the heart. Nature (1958) 0.97
Mode of action of antigen and other smooth-muscle stimulants. Science (1957) 0.96
Potentiating action of chlorpromazine and reserpine. Nature (1955) 0.95
Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. J Pharmacol Exp Ther (1956) 0.95
Persistence of reserpine action after the disappearance of drug from brain: effect on serotonin. J Pharmacol Exp Ther (1956) 0.92
Anticonvulsant properties of monoamine oxidase inhibitors. Ann N Y Acad Sci (1959) 0.89
Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action. Science (1956) 0.89
On the physiologic significance of monoamine oxidase in brain. Science (1957) 0.87
LSD-like effects elicited by reserpine in rabbits pretreated with iproniazid. Proc Soc Exp Biol Med (1957) 0.83
A microfluorometric method for the determination of agmatine. Anal Biochem (1961) 0.81
Effect of reserpine, serotonin, and 5-hydroxytryptophan on rabbit platelet histamine in vivo and in vitro. Biochem Pharmacol (1960) 0.81
PLATELET DAMAGE INDUCED IN PLASMA BY CERTAIN FATTY ACIDS. Nature (1963) 0.81
Sex difference in histamine metabolism in the rat. Am J Physiol (1961) 0.80
INTRACELLULAR DISTRIBUTION OF METARAMINOL AND RELATED COMPOUNDS IN RAT HEART. Life Sci (1965) 0.79
The mechanism of the Schultz-Dale reaction. J Allergy (1959) 0.79
Observations on the fate of dromoran in the dog and its secretion into the gastric juice. J Pharmacol Exp Ther (1955) 0.77
An interpretation of the action of psychotropic drugs. Postgrad Med (1958) 0.77
On the reported inhibition of monoamine oxidase by an agent with sedative properties. Science (1960) 0.77
Release of rabbit platelet histamine by serum in vitro. Am J Physiol (1962) 0.75
Biochemical, physiological, and pharmacological aspects of serotonin. Recent Prog Horm Res (1957) 0.75
Possible mechanism of antidepressant action of marsilid. J Clin Exp Psychopathol (1958) 0.75
THE EFFECT OF DESMETHYLIMIPRAMINE ON RESERPINE AND INSULIN-INDUCED RELEASE OF GASTRIC HISTAMINE AND ADRENAL CATECHOLAMINES. Life Sci (1964) 0.75
FLUOROMETRIC MEASUREMENT OF HISTAMINE. Methods Med Res (1964) 0.75
An anticonvulsant effect of monoamine oxidase inhibitors. Experientia (1959) 0.75
Recent biochemical developments with monoamine oxidase inhibitors. Dis Nerv Syst (1960) 0.75
Effect of iproniazid on brain levels of norepinephrine and serotonin. Science (1958) 0.75
[Histamine metabolism in male and female rats]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1961) 0.75